Immunotherapy is a modern cancer treatment that helps the body’s immune system recognize and attack cancer cells. While it works remarkably well for some patients, others see little or no benefit. This happens because both cancers and immune systems are different in every person.
Cancer Visibility to the Immune System
i) Some cancers carry many genetic mutations, making them easier for the immune system to detect
ii) Other cancers look very similar to normal cells, allowing them to hide from immune attack
Role of the Tumor Environment
The area around a tumor greatly affects treatment response.
i) Some tumors are already surrounded by immune cells, which can be activated by immunotherapy
ii) Others create a suppressive environment that blocks immune cells, reducing effectiveness
Why Patient Biology Matters?
Factors such as immune strength, genetics, previous treatments, and even gut health influence how well immunotherapy works. Patients with a strong and balanced immune system often respond better.
Importance of Biomarkers
Biomarkers like PD-L1 expression, tumor mutation burden (TMB), and MSI status help doctors predict who is most likely to benefit from immunotherapy. These markers guide personalized treatment decisions.
Future of Immunotherapy
Ongoing research aims to discover better biomarkers and develop combination therapies so that more patients can benefit from immunotherapy.
At Sayre Therapeutics, we support advances in immuno-oncology and personalized cancer
care to improve patient outcomes.
